(Press-News.org) Metastasis is bad news for cancer patients. Northwestern University scientists now have demonstrated a simple but powerful tool that can detect live cancer cells in the bloodstream, potentially long before the cells could settle somewhere in the body and form a dangerous tumor.
The NanoFlare technology is the first genetic-based approach that is able to detect live circulating tumor cells out of the complex matrix that is human blood -- no easy feat. In a breast cancer study, the NanoFlares easily entered cells and lit up the cell if a biomarker target was present, even if only a trace amount. The NanoFlares are tiny spherical nucleic acids with gold nanoparticle cores outfitted with single-stranded DNA "flares."
"This technology has the potential to profoundly change the way breast cancer in particular and cancers in general are both studied and treated," said Chad A. Mirkin, a nanomedicine expert and a corresponding author of the study.
Mirkin's colleagues C. Shad Thaxton, M.D., and Chonghui Cheng, M.D., both of Northwestern University Feinberg School of Medicine, are also corresponding authors.
The research team, in a paper to be published the week of Nov. 17 by the Proceedings of the National Academy of Sciences (PNAS), reports two key innovations:
The ability to track tumor cells in the bloodstream based on genetic content located within the cell itself, as opposed to using proteins located on the cell's surface (current technology)
The ability to collect the cells in live form, so they may be studied and used to inform researchers and clinicians as to how to treat a disease -- an important step toward personalized medicine
"Cancers are very genetically diverse, and it's important to know what cancer subtype a patient has," Mirkin said. "Now you can think about collecting a patient's cells and studying how those cells respond to different therapies. The way a patient responds to treatment depends on the genetic makeup of the cancer."
Mirkin is the George B. Rathmann Professor of Chemistry in the Weinberg College of Arts and Sciences and professor of medicine, chemical and biological engineering, biomedical engineering and materials science and engineering.
A NanoFlare is designed to recognize a specific genetic code snippet associated with a cancer. The core nanoparticle, only 13 nanometers in diameter, enters cells, and the NanoFlare seeks its target. If the genetic target is present in the cell, the NanoFlare binds to it and the reporter "flare" is released to produce a fluorescent signal. The researchers then can isolate those cells.
"The NanoFlare turns on a light in the cancer cells you are looking for," said Thaxton, an assistant professor of urology at Feinberg. "That the NanoFlares are effective in the complex matrix of human blood is a great technical advance. We can find small numbers of cancer cells in blood, which really is like searching for a needle in a haystack."
Once they identified the cancer cells, the researchers were able to separate them from normal cells. This ability to isolate, culture and grow the cancer cells will allow researchers to zero in on the cancer cells that matter to the health of the patient. Most circulating tumor cells may not metastasize, and analysis of the cancer cells could identify those that will.
"This could lead to personalized therapy where we can look at how an individual's cells respond to different therapeutic cocktails," said Mirkin, whose lab developed NanoFlares in 2007.
In the study, the genetic targets were messenger RNA (mRNA) that code for certain proteins known to be biomarkers for aggressive breast cancer cells.
The research team first used the blood of healthy individuals, spiking some of the blood with living breast cancer cells to see if the NanoFlares could detect them. (Unspiked blood was used as a control.)
Cheng, an assistant professor of medicine in hematology/oncology at Feinberg, provided the cell lines and NanoFlare targets the researchers used to model blood samples taken from breast cancer patients.
The research team tested four different NanoFlares, each with a different genetic target relevant to breast cancer metastasis. The technology successfully detected the cancer cells with less than 1 percent incidence of false-negative results.
Currently, in another study, the researchers are focused on detecting circulating tumor cells in the blood of patients with a diagnosis of breast cancer.
"When it comes to detecting and treating cancer, the mantra is the earlier, the better," Thaxton said. "This technology may enable us to better detect circulating cancer cells and provides another tool to add to the toolkit of cancer diagnosis."
INFORMATION:
Mirkin, Thaxton and Cheng are members of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
The title of the paper is "NanoFlares for the detection, isolation, and culture of live tumor cells from human blood."
In addition to Mirkin, Thaxton and Cheng, other authors of the paper are Tiffany L. Halo (co-first author), Kaylin M. McMahon (co-first author), Nicholas L. Angeloni, Yilin Xu, Wei Wang and Alyssa B. Chinen, all from Northwestern University, and Vincent L. Cryns, Dmitry Malin and Elena Strekalova, from the University of Wisconsin School of Medicine and Public Health.
Editor's note: Chad Mirkin and Shad Thaxton have interest in AuraSense, a biotechnology company that licensed the NanoFlare technology from Northwestern University. Mirkin and Thaxton are co-founders of the company.
SALT LAKE CITY, Nov. 17, 2014 - Whether birds are breathing in or out, air flows in a one-directional loop through their lungs. This pattern was unexpected and for decades, biologists assumed it was unique to birds, a special adaptation driven by the intense energy demands of flight.
But that view is wrong, according to University of Utah scientists who now have shown that bird-like breathing also developed in green iguanas - reptiles not known for high-capacity aerobic fitness. The finding bolsters the case that unidirectional bird-like flow evolved long before the first ...
MONTREAL: An infant's mother tongue creates neural patterns that the unconscious brain retains years later even if the child totally stops using the language, (as can happen in cases of international adoption) according to a new joint study by scientists at the Montreal Neurological Institute and Hospital - The Neuro and McGill University's Department of Psychology. The study offers the first neural evidence that traces of the "lost" language remain in the brain.
"The infant brain forms representations of language sounds, but we wanted to see whether the brain maintains ...
November 17, 2014--Museum biological collections are the records of life on Earth and as such, they are frequently used to investigate serious environmental issues. When public health officials were concerned about the levels of mercury in fish and birds, for example, scientists studied museum specimens to assess historical changes in mercury contamination. Eggs in museum collections were analyzed to establish the connection between DDT, thinning eggshells, and the decline in bird populations. And now, specimens from the Natural History Museum of Los Angeles County (NHM) ...
CHICAGO - Black patients who have been diagnosed with heart failure are no less likely than white patients to get atrial fibrillation (an irregular heartbeat, or arrhythmia), according to a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania, which was presented today at the 2014 Scientific Sessions of the American Heart Association. These findings run counter to previous studies, which have found that black patients with heart failure tend to have less atrial fibrillation problems than white patients.
"Even though ...
ROCHESTER, Minn. -- The investigational drug ixazomib taken orally in combination with lenalidomide and dexamethasone shows promise in patients with newly diagnosed multiple myeloma, according to the results of a phase 1/2 study published in the journal Lancet Oncology.
"Ixazomib is an investigational, oral proteasome inhibitor with promising anti-myeloma effects and low rates of peripheral neuropathy," says Shaji Kumar, M.D., a hematologist at Mayo Clinic and lead author of the study. "While it is well known that a combination of bortezomib, lenalidomide and dexamethasone ...
iRhythm Technologies, Inc. announced today that study results presented during the American Heart Association (AHA) Scientific Sessions showed an association between a high burden of atrial fibrillation (AFib) and lower cognitive function, specifically executive and verbal function. Previous studies have shown a relationship between AFib, cognitive decline and increased risk of dementia. However, this study, which was led by researchers at the University of Minnesota, demonstrates for the first time a correlation between high AFib burden - the percent of time a person has ...
Amsterdam, NL, 17 November 2014 - Two simple tests conducted during the neurological exam can help clinicians differentiate between early-stage Parkinson's disease (PD) and atypical parkinsonism. By asking patients to perform a tandem gait test and inquiring whether they are still able to ride a bicycle, clinicians can ascertain whether medio-lateral balance is impaired, a defining characteristic of atypical parkinsonism. These findings are published in the Journal of Parkinson's Disease.
This issue of the Journal of Parkinson's Disease also marks the inauguration of ...
Why is Jamaica, with a population smaller than that of Los Angeles, home to so many of the world's elite sprinters - runners who compete in the 100, 200, 400 and 800-meter races?
Robert Trivers, an evolutionary biologist and professor of anthropology and biology in the School of Arts and Sciences, set out with his colleagues to find out if there was something about the symmetry of their knees that might partly explain this phenomenon. They already knew from their earlier research that the symmetry of children's knees at age 8 predicts how fast a person runs 14 years later ...
The sun emitted a mid-level solar flare, peaking at 12:48 p.m. EST on Nov. 16, 2014. NASA's Solar Dynamics Observatory, which watches the sun constantly, captured an image of the event. Solar flares are powerful bursts of radiation. Harmful radiation from a flare cannot pass through Earth's atmosphere to physically affect humans on the ground, however -- when intense enough -- they can disturb the atmosphere in the layer where GPS and communications signals travel.
To see how this event may affect Earth, please visit NOAA's Space Weather Prediction Center at http://spaceweather.gov, ...
Here's another reason to pay close attention to microbes: Current climate models probably overestimate the amount of carbon that will be released from soil into the atmosphere as global temperatures rise, according to research from the US Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab).
The findings are from a new computer model that explores the feedbacks between soil carbon and climate change. It's the first such model to include several physiologically realistic representations of how soil microbes break down organic matter, a process that ...
